WuXi AppTec and Insilico Medicine Link Next-Generation Artificial Intelligence and Drug Discovery
WuXi AppTec and Insilico Medicine establish a close strategic collaboration to integrate next-generation artificial intelligence with drug discovery BALTIMORE, Maryland and SHANGHAI, June 12, 2018 /PRNewswire/ -- Insilico Medicine, aBaltimore-based next-generation artificial intelligence company ...
2018-06-12 10:40
2671
WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange
SHANGHAI, May 7, 2018 /PRNewswire/ -- WuXi AppTec Co., Ltd. ("WuXi AppTec" or "the Company"; Stock Code: 603259), a leading global pharmaceutical and medical device open-access capability and technology platform company, today announced listing of its initial public offering of 104,198,600 shar...
2018-05-08 11:44
1901
